Hospital‐wide massive transfusion over time: Indications, treatment strategies, and clinical outcomes
Vox Sanguinis · 03.11.2026
DOI: 10.1111/vox.70405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 03.11.2026. Verfasst von Anna Gustafsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stockholms Läns Landsting, Stockholm läns landsting.
Abstract (Originalsprache)
Background and Objectives Massive transfusion (MT) is a lifesaving intervention for severe hemorrhage. Contemporary data on indications, transfusion practices, and outcomes across a broad in‐hospital population remain limited. Materials and Methods This retrospective cohort study included adult patients receiving MT at Karolinska University Hospital between 2016 and 2021. MT was defined as transfusion of ≥10 red blood cell (RBC) units within 24 h. Data were obtained from the hospital transfusion registry and medical records.
Results
A total of 486 MT events were identified. Median age was 60 years (interquartile range [IQR] 46–70), and 65.6% of patients were male. The most common indications were trauma (15.6%), abdominal cancer surgery (15.0%), cardiothoracic surgery (14.0%), and vascular surgery (12.3%). The overall median RBC:plasma:platelet ratio was 5:5:1, consistent with balanced transfusion strategies. MT was more frequently associated with acute than elective procedures (67.2% vs. 32.8%, p < 0.001). Fibrinogen, tranexamic acid, and prothrombin complex concentrate were administered in 69.5%, 52.1%, and 13.6% of cases, respectively. Mortality was 10.3% at 24 h and 31.7% at 30 days. The annual number of MT events decreased significantly during the study period ( p < 0.001), corresponding to an approximately 40% reduction between 2016 and 2021.
Conclusion
MT was required across a wide range of surgical and medical specialties and remained associated with substantial mortality. Balanced transfusion strategies were well implemented, whereas the use of adjunct hemostatic therapies varied considerably. The marked reduction in MT events over time suggests improvements in hemorrhage management and bleeding control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Vascular Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden.
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Anna Gustafsson, Carl-Magnus Wahlgren, Mattias Günther, Agneta Wikman
Förderung
- Stockholms Läns Landsting
- Stockholm läns landsting
Zitieren
APA
Gustafsson, A., Wahlgren, C. M., Günther, M., Cruz, I. R., & Wikman, A. (2026). Hospital‐wide massive transfusion over time: Indications, treatment strategies, and clinical outcomes. Vox Sanguinis. https://doi.org/10.1111/vox.70405
Vancouver
Gustafsson A, Wahlgren CM, Günther M, Cruz IR, Wikman A. Hospital‐wide massive transfusion over time: Indications, treatment strategies, and clinical outcomes. Vox Sanguinis. 2026. doi:10.1111/vox.70405
BibTeX
@article{Gustafsson2026,
author = {Gustafsson, Anna and Wahlgren, Carl-Magnus and Günther, Mattias and Cruz, Ivette Raices and Wikman, Agneta},
title = {Hospital‐wide massive transfusion over time: Indications, treatment strategies, and clinical outcomes},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70405}
}
EUVIMED